New Delhi: India on Wednesday said that Biological E’s COVID-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country’s other two main shots, Covaxin and AstraZeneca’s Covishield, from August 12 (Friday).
Corbevax will be available to over to those above the age of 18, as a precautionary booster six months after a second dose, the health ministry said in an August 8 letter to state authorities and shared with reporters on Wednesday.
Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin.
India has so far administered more than 2 billion COVID vaccine shots, including 113 million boosters, all of which have so far been of the same vaccine as the recipient’s first two doses. The government says about 89% of Indians above the age of 12 have had two doses.
New Delhi: President-elect Donald Trump on Friday announced that Robert F Kennedy Jr. would lead…
Bhubaneswar/Cuttack: People gathered at Gadagadia Ghat in Cuttack and Bindu Sagar tank in Bhubaneswar before…
New Delhi: Former heavyweight champion Mike Tyson slapped opponent Jake Paul as the two men…
Bhubaneswar: Can the Italian risotto be cooked and served in an Odia tribal style? Believe…
Berhampur: A stone weighing 2 kg fell from the ‘Singhadwara Gumuta’ of the Lord Jagannath…
New Delhi: Recent pictures of Space Station Commander Sunita Williams from the International Space Station…
Mumbai: Actress Rupali Ganguly recently filed a Rs 50 crore defamation case against her stepdaughter…
Chennai: Odisha will face Manipur in the semifinals of the 14th Hockey India Senior Men’s…